Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lornoxicam for Acute Migraine Headache
NCT00293657Phase 2Completed
- Sponsor
- Pozen
- Start
- Dec 2005
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lornoxicam in migraine (3 arms), sponsored by Pozen. Primary endpoint: Assessment of headache pain intensity at 24 hours. Started Dec 2005; status: completed.
02
Drugs
lornoxicam
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00293657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293657.